HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Noncoordinate changes in the components of ribonucleotide reductase in mammalian cells.

Abstract
Ribonucleotide reductase from mammalian cells consists of two nonidentical components which are both required for enzymatic activity. It was found that the addition of the effector-binding component (dye fraction) to cell-free extracts of Ehrlich tumor cells stimulated CDP reductase activity. The decrease in CDP reductase activity which accompanied the decrease in Ehrlich tumor cell proliferation in vivo could be correlated with the decrease in the dye fraction component. In regenerating liver, the reductase activity was increased maximally at 36 h following partial hepatectomy. This activity could be further stimulated by exogenous tumor cell dye fraction. The non-heme iron component (Tris fraction) was isolated and quantitated from the liver extracts of regenerating livers. The maximal increase on the Tris fraction component was observed in the 24-h regenerating liver. These data provide evidence that the components making up the active ribonucleotide reductase species are not coordinately increased at the time of the increase in reductase activity.
AuthorsJ G Cory, A E Fleischer
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 257 Issue 3 Pg. 1263-6 (Feb 10 1982) ISSN: 0021-9258 [Print] United States
PMID7035447 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Macromolecular Substances
  • CDP reductase
  • Ribonucleotide Reductases
  • Ribonucleoside Diphosphate Reductase
Topics
  • Animals
  • Carcinoma, Ehrlich Tumor (enzymology)
  • Female
  • Kinetics
  • Liver (enzymology)
  • Liver Regeneration
  • Macromolecular Substances
  • Male
  • Mice
  • Mice, Inbred ICR
  • Rats
  • Rats, Inbred Strains
  • Ribonucleoside Diphosphate Reductase (metabolism)
  • Ribonucleotide Reductases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: